NYSE$NHC

National HealthCare Corporation · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

NHC reported an increase in net operating revenues driven by occupancy and acquisition of Caris Healthcare, but experienced a decrease in adjusted net income due to less government stimulus and higher labor costs.

National HealthCare Corporation reported an 11.2% increase in net operating revenues and grant income for Q1 2022, reaching $278,983,000. However, net income attributable to NHC decreased to $15,318,000, and adjusted net income also declined due to reduced government stimulus and higher labor costs.

  • Net operating revenues and grant income increased by 11.2% to $278,983,000 compared to Q1 2021.
  • The increase in net operating revenues was primarily driven by occupancy in skilled nursing facilities and the acquisition of Caris Healthcare.
  • Net income attributable to NHC was $15,318,000, compared to $21,267,000 for the same period in 2021.
  • GAAP diluted earnings per share were $0.99, compared to $1.38 for the same period in 2021.

Headline financials

Total Revenue

$279M

Previous: $251M+11.2%
EPS (adj)

$0.91

Previous: $1.08-15.7%
Capital Expenditures

-$8.96M

Previous: -$4.33M-107.1%
Free Cash Flow

$6.36M

Previous: $16.9M-62.5%
Net Income

$15.3M

Previous: $21.3M-28.0%
Operating Income

$14.2M

Previous: $15.2M-6.6%
Gross Profit

$279M

Previous: $251M+11.2%
Cash & Equivalents

$57M

Previous: $134M-57.5%
Total Assets

$1.36B

Previous: $1.36B+0.1%
Stock-Based Comp

$712K

Previous: $496K+43.5%

Revenue & EPS history

NHC · Revenue · Quarterly

$279M

Q1 2022+11.2%vs Q1 2021

Revenue by segment

NHC · $267M total across 2 segments · Q1 2022

  • Net patient revenues
    $251M+10.9%
  • Other revenues
    $16.5M+13.5%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro